






Internationalizing Brazilian Pharmaceutical Sciences
Internationalization is the watchword today! Every single university, research institutes and areas of 
science are going for it. To be part of the globalized world is the main goal for every institution all over the 
planet in the 21st century. Although the effort started at the end of the last century, it grew stronger in the New 
Millennium. 
What is the importance of being more and more international? In the scope of Higher Education In-
stitutions it means to upgrade human resources with higher quality, both among undergraduate and graduate 
students, and also to allow faculty, staff and researchers to update towards better expertise and qualification. 
Besides, sharing cultural diversity represents not only professional but also personal experience, which con-
tributes to turn a person into a better human being.
In this point of view, it is also important to look for the internationalization of the science we have 
been developing. In Brazil, Pharmaceutical Sciences comprehend not only Drugs and Medicines as in most 
countries all over the world, but also Food and Experimental Nutrition, and Clinical and Toxicological Analy-
sis. It is important to think about how those areas are being developed in other countries and to compare our 
indicators with world parameters.
SCImago Journal and Country Rank (www.scimagojr.com) is a portal that contains journals and sci-
entific indicators from Scopus data base. The indicators have been used to analyze the scientific scenario of 
the countries compared with each other and with those in selected regions worldwide. Publications involving 
international collaboration can reflect the level of internationalization of a determined scientific area. 
Concerning Pharmaceutical Sciences in Brazil, SCImago indicators point to an increment in interna-
tional collaboration from around 15% in 1996 to about 17% in 2012, with fluctuations along the period. A 
maximum value of 26% was observed in 2008 and a minimum, around 5%, in 2000. It is possible to observe 
that Brazil meets the same pattern as that in Latin America, whose percentage of international collaboration 
was approximately 22% in 2012. This means that Brazil contributes significantly to the international collabo-
ration in this continent. It is worth noting that the highest differences concerning international collaboration 
were observed between our country and Western Europe.
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Those features of Brazilian Pharmaceutical Sciences lead us to search for increasing significantly the 
insertion of this area worldwide. This depends on the quality of research we have been developing, so as to 
increase the opportunities of international collaboration. And increasing the international collaboration will 
increase the quality of our research, in a virtuous cycle. 
So, let us do our best to make Brazilian Pharmaceutical Sciences recognized worldwide!
 Elizabeth Igne Ferreira
 Scientific Editor
